Politics

Business

Sports

Lifestyle

Health

Novo Sues Hims Over Obesity Drug Copycats

Novo Nordisk has filed a lawsuit against Hims & Hers Health alleging patent infringement on semaglutide, escalating tensions between the companies after their partnership dissolved last year.